← FDA Drug Approvals (Drugs@FDA)

TRETINOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2023-01-05

Drug application

FDA Application #
ANDA215713
Application type
Abbreviated New Drug Application (Generic)
Brand name
TRETINOIN
Generic name
TRETINOIN
Active ingredients
TRETINOIN
Dosage form
CREAM
Route
TOPICAL
Marketing status
Prescription
Sponsor
SUN PHARMA CANADA
Manufacturer
NORTHSTAR RX LLC
First approval
2023-01-05

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown